ACTRN12611000240943招募中未知
Treating worry and rumination in individuals with anxiety and depression using Acceptance and Commitment Therapy, measuring symptom reduction, acceptance-based attitudes, level of disability and engagement in valued living
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years(—)
- 性别
- All
入选标准
- •A diagnosis of major depressive disorder, dysthymic disorder or an anxiety disorder where worry and rumination are prominent features. Each participant’s eligibility will be assessed using the depression and anxiety modules of the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (Patient Edition, with Psychotic Screen; First, Gibbon, Spitzer, & Williams, 2007).
排除标准
- •Individuals who meet the inclusion criteria but who have co-morbid psychosis, suicidal intent, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder or an eating disorder will be excluded from participating in the study.
研究者
相似试验
已完成
不适用
Reducing distress from somatic symptomsISRCTN11688040niversity of Southampton12
已完成
不适用
Anxiety and behavioral problems in people with intellectual disabilities. A guideline for multidimensional diagnostics of anxiety and behavioral problems in patients with intellectual disability: research on process and outcomesanxiety and behavioral problems10002861NL-OMON33096Hogeschool INHolland60
尚未招募
Unknown
The impact of spiritual meditation on cancer patientsIRCT20240409061454N1Esfahan University of Medical Sciences50
招募中
Unknown
A study of treatment of general malaise with conditioned mediumFatigue SyndromeD015673JPRN-jRCT1051220089Inami Norihito20
已完成
不适用
The effects of reducing worry in patients with persecutory delusions: finding out if worries can be reduced by brief cognitive therapyPersecutory delusions in the context of schizophrenia or related diagnosisMental and Behavioural DisordersSchizophrenia or related diagnosisISRCTN23197625The Efficacy and Mechanism Evaluation Programme (MRC/NIHR) (UK)150
